- Details
- Description
Packaging Size:
42 tablets per bottle
Strength:
200 mg
Composition:
Adagrasib INN 200 mg per tablet
Treatment:
Targeted treatment for adults with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC) after prior systemic therapy; also used with cetuximab for certain KRAS G12C-mutated metastatic colorectal cancer.
Form:
Film-coated tablet
Brand:
Adakras 200 mg
Quantity Unit:
Tablet
Manufacturer:
Everest Pharmaceuticals Ltd., Bangladesh
Adakras 200 mg Tablet (Adagrasib INN 200 mg) is an oral targeted anticancer medicine containing adagrasib, an irreversible KRAS G12C inhibitor. It works by blocking the abnormal KRAS G12C protein that can drive cancer-cell growth. It is used for adults with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC) after at least one prior systemic treatment, and in certain cases of KRAS G12C-mutated advanced colorectal cancer in combination with cetuximab.
